For research use only
| Cat No. | ABC-X0256C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Epithelial-like |
| Species | Human |
| Host Cell | HepG2 |
| Source Organ | Liver |
| Disease | Hepatoblastoma |
| Storage | Liquid Nitrogen |
Xpress™ Human TPBG over-expressing HepG2 cells enable hepatocellular carcinoma research focused on tumor progression and TPBG signaling pathways.
Xpress™ Human TPBG Overexpression Cell Line (HepG2) is a genetically engineered model derived from selected human hepatocellular carcinoma HepG2 parental cell line based on customers’ requirement. TPBG HepG2 overexpression cell line is generated by stable integration of exogenous human TPBG into HepG2 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
TPBG (Trophoblast Glycoprotein), also known as 5T4, is a transmembrane protein associated with embryonic development and tumor progression. It plays a role in cell adhesion, migration, and immune modulation. Its expression is upregulated in various cancers, including hepatocellular carcinoma, and correlates with poor prognosis and metastatic potential.
AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0256C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Liver |
| Disease | Hepatoblastoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | HepG2 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The TPBG HepG2 Overexpression Cell Line serves as a powerful tool to investigate TPBG-driven oncogenic mechanisms and therapeutic interventions. This model enables studies on tumor cell motility, immune evasion, and epithelial-mesenchymal transition. It is suitable for screening of 5T4-targeted therapies and antibody-based therapeutics.